Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunoglobulin a Nephropathy”

429 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 429 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07642050
What this trial is testing

Determine if BHV-1400 is Effective and Safe in Adults With IgA Nephropathy

Who this might be right for
IgA Nephropathy
Biohaven Therapeutics Ltd. 420
Post-approval studies (Phase 4)UnknownNCT05824390
What this trial is testing

A Randomized, Controlled Clinical Study of Rituximab in Treatment of Primary IgA Nephropathy

Who this might be right for
IgA Nephropathy
XIEJINGYUAN 116
Not applicableStudy completedNCT01451710
What this trial is testing

The Effectiveness of Enough Steroids as Inducement Therapy in Minimal Change Disease-like IgA Nephropathy

Who this might be right for
IgA Nephropathy
Nanjing University School of Medicine 30
Testing effectiveness (Phase 2)Study completedNCT02335918
What this trial is testing

A Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck (SCCHN)Ovarian Carcinoma-Enrollment CompletedColorectal Cancer (CRC)-Enrollment Completed+2 more
Celldex Therapeutics 175
Large-scale testing (Phase 3)UnknownNCT03357653
What this trial is testing

Beginning of Effective and Safe Treatment in Immunoglobulin A-1 Nephropathy-1

Who this might be right for
Glomerulonephritis, Immunoglobulin A (IgA)
Ewha Womans University 174
Early research (Phase 1)Ended earlyNCT05061537
What this trial is testing

Study of PF-07263689 in Participants With Selected Advanced Solid Tumors

Who this might be right for
Renal Cell CancerMelanomaNon-Small-Cell Lung Cancer+7 more
Pfizer 13
Not applicableUnknownNCT05797051
What this trial is testing

Application of Hyperspectral Imaging in the Diagnosis of Glomerular Diseases

Who this might be right for
Glomerulonephritis, IGAGlomerulonephritis, MembranousDiabetic Nephropathies+2 more
Qianfoshan Hospital 80
Not applicableLooking for participantsNCT03929887
What this trial is testing

KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis

Who this might be right for
Glomerular DiseaseMinimal Change DiseaseIgA Nephropathy+4 more
Seoul National University Hospital 3,000
Large-scale testing (Phase 3)Not Yet RecruitingNCT07052981
What this trial is testing

Clinical Study on the Efficacy and Safety of Telitacicept in the Treatment of Pediatric IgA Nephropathy or IgA Vasculitis Nephritis

Who this might be right for
IgA Nephropathy (IgAN)IgAVN
Guixia Ding 124
Not applicableStudy completedNCT07607002
What this trial is testing

Assessing the Global Burden of IgA Nephropathy (IgAN) in Patients Receiving Hemodialysis: A Real-World Study Using DOPPS Data

Who this might be right for
IgAN - IgA Nephropathy
Arbor Research Collaborative for Health 70,000
Not applicableUnknownNCT06393036
What this trial is testing

The Effect of OSA on Severity and Prognosis of Patients With IgAN

Who this might be right for
Obstructive Sleep ApneaIgA Nephropathy
Peking University First Hospital 200
Early research (Phase 1)Study completedNCT05314231
What this trial is testing

Safety and Pharmacokinetic Study of Subcutaneous ALXN1720 in Participants With Proteinuria

Who this might be right for
Proteinuria
Alexion Pharmaceuticals, Inc. 13
Not applicableUnknownNCT01781312
What this trial is testing

Probiotics in IgA Nephropathy

Who this might be right for
IgA Nephropathy
Uppsala University Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00396721
What this trial is testing

Sirolimus Therapy for Poor Prognosis Immunoglobulin A Nephropathy

Who this might be right for
Glomerulonephritis, IGANephropathy, IGAIGA Nephropathy
Josep m Cruzado 23
Early research (Phase 1)Active Not RecruitingNCT06294236
What this trial is testing

Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM)

Who this might be right for
Lupus ErythematosusSystemic Lupus ErythematosusSLE (Systemic Lupus)+3 more
Sana Biotechnology 7
Not applicableStudy completedNCT00391287
What this trial is testing

Surveillance Study to Estimate the Incidence of Pure Red Blood Cell Aplasia Among Patients With Chronic Kidney Failure

Who this might be right for
Pure Red-Cell AplasiaChronic Kidney Failure
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 15,334
Large-scale testing (Phase 3)Not Yet RecruitingNCT05596708
What this trial is testing

Study of Telitacicept in Patients With Refractory IgA Nephropathy

Who this might be right for
IgA Nephropathy
Second Affiliated Hospital, Zhejiang University, School of Medicine 40
Large-scale testing (Phase 3)Looking for participantsNCT05935215
What this trial is testing

Efficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study Participants With Atypical Hemolytic Uremic Syndrome (aHUS)

Who this might be right for
Atypical Hemolytic Uremic Syndrome
Novartis Pharmaceuticals 50
Early research (Phase 1)Not Yet RecruitingNCT07234474
What this trial is testing

A Phase I Study of YK012 in Primary Membranous Nephropathy

Who this might be right for
Primary Membranous Nephropathy
Excyte Biopharma Ltd 66
Not applicableStudy completedNCT05200871
What this trial is testing

Humanistic Burden of (FSGS) Focal Segmental Glomerulosclerosis and IgAN (Immunoglobulin A Nephropathy)

Who this might be right for
Focal Segmental GlomerulosclerosisImmunoglobulin A Nephropathy
Travere Therapeutics, Inc. 487
Next Page